A DNAJB1-PRKACA fusion kinase peptide vaccine for patients with fibrolamellar hepatocellular carcinoma

Case ID:
C16157
Unmet Need
Fibrolamellar carcinoma (FLC) is an extremely rare form of cancer. It affects both men and women in approximately 1 in 5,000,000 people with greater frequency among young adults with a median age of diagnosis of 25. Unfortunately, there is no standard of care therapy for this cancer, and patients with this disease have an expected median survival of approximately 12 months.

Technology Overview
Hopkins researchers have designed a vaccine targeting a unique fibrolamellar carcinoma oncogenic fusion protein, involving a kinase, which was recently identified as the signature genetic event initiating FLC. The researchers developed a novel vaccine for the treatment for fibrolamellar hepatocellular carcinoma (FL-HCC). The vaccine is based upon a peptide encoded by the fusion gene and a concomitant adjuvant. Having tested their FL-HCC vaccine in mice, in vivo data demonstrated a marked delay in tumor growth, as well as, significantly reduced tumor volume and growth rate.

This fusion protein has also been identified in other cancers, including pancreatic and biliary cancers. If proven clinically successful, this could be developed further as a new therapeutic approach to this lethal form of liver malignancy. This fusion kinase target may be an expanded opportunity for neoantigen-specific immunotherapy in other indications.

Stage of Development
A human clinical trial has been fully funded by the Fibrolamellar Cancer Foundation and Bristol-Meyer-Squibb with patient recruitment beginning soon.

Publications
N/A

 
Patent Information:
Title App Type Country Serial No. Patent No. File Date Issued Date Expire Date Patent Status
FUSION PROTEINS AND METHODS OF USE THEREOF PCT: Patent Cooperation Treaty European Patent Office 20908778.2   12/31/2020     Pending
FUSION PROTEINS AND METHODS OF USE THEREOF PCT: Patent Cooperation Treaty United States 17/789,858   6/29/2022     Pending
Inventors:
Category(s):
Get custom alerts for techs in these categories/from these inventors:
For Information, Contact:
Jeanine Pennington
jpennin5@jhmi.edu
410-614-0300
Save This Technology:
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum